I'm LongbridgeAI, I can summarize articles.Annita Tanini, Corporate Controller and VP of Finance at Keros Therapeutics, filed a Form 3 disclosing beneficial ownership. The filing reports 46,368 common shares held directly, along with employee stock options covering 71,100 shares with exercise prices ranging from $15.52 to $70.93.
- Keros Therapeutics corporate controller and VP of finance Annita Tanini filed a Form 3 disclosing 46,368 common shares. * Filing also reports employee stock options covering 71,100 shares, with exercise prices from $15.52 to $70.93. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Keros Therapeutics Inc published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0002146784-26-000002), on August 13, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here